Advertisement
Advertisement
MDT
Medtronic plc
88.17
USDSponsored
+1.03
+1.18%
Mar 16, 15:59 UTC -4
Closed
After-Market
88.56
+0.40
+0.45%
MDT Earnings Reports
Positive Surprise Ratio
MDT beat 30 of 41 last estimates.
73%
Next Report
Date of Next Report
May 20, 2026
Estimate for Q4 26 (Revenue/ EPS)
$9.75B
/$1.67
Implied change from Q3 26 (Revenue/ EPS)
+8.10%
/+22.79%
Implied change from Q4 25 (Revenue/ EPS)
+9.19%
/+3.09%
Medtronic plc earnings per share and revenue
On Feb 17, 2026, MDT reported earnings of 1.36 USD per share (EPS) for Q3 26, beating the estimate of 1.34 USD, resulting in a 0.89% surprise. Revenue reached 9.02 billion, compared to an expected 8.99 billion, with a 0.25% difference. The market reacted with a -3.10% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 29 analysts forecast an EPS of 1.67 USD, with revenue projected to reach 9.75 billion USD, implying an increase of 22.79% EPS, and increase of 8.10% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
Viemed Healthcare, Inc. Common Shares
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.12
Actual
$0.14
Surprise
+10.85%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Immucell Corp
Report Date
Mar 04, 2026 For Q4 25
Estimate
-Actual
-$0.31
Surprise
-
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Medtronic plc's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Medtronic plc reported EPS of $1.36, beating estimates by 0.89%, and revenue of $9.02B, 0.25% above expectations.
How did the market react to Medtronic plc's Q3 2026 earnings?
The stock price moved down -3.1%, changed from $99.49 before the earnings release to $96.41 the day after.
When is Medtronic plc expected to report next?
The next earning report is scheduled for May 20, 2026.
What are the forecasts for Medtronic plc's next earnings report?
Based on 29
analysts, Medtronic plc is expected to report EPS of $1.67 and revenue of $9.75B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement